Lawsuit for Investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) announced by Shareholders Foundation

Wednesday, January 18, 2017 2:50 PM UTC

SAN DIEGO, Jan. 18, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Abeona Therapeutics Inc (NASDAQ:ABEO) over alleged Securities Laws Violations by Abeona Therapeutics Inc.

Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ: ABEO) have certain options and for certain investors there are short and strict deadlines running. Deadline: February 14, 2017. NASDAQ:ABEO investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the science behind Abeona’s proposed gene therapy treatment for Sanfilippo syndrome is unviable, that Steven H. Rouhandeh, Abeona Therapeutics, Inc’s Executive Chairman and Principal Executive Officer, previously worked in a high ranking position for a biotech promoter who was convicted of securities fraud and involved in manipulating biotech stocks, and that as a result, Defendants’ statements about Abeona Therapeutics, Inc’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased Abeona Therapeutics Inc (NASDAQ: ABEO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:  Shareholders Foundation, Inc.
          Michael Daniels
          +1 (858) 779-1554
          [email protected]
          3111 Camino Del Rio North
          Suite 423
          San Diego, CA 92108

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Lawsuit for Investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) announced by Shareholders Foundation

Editor's Picks

Welcome to EconoTimes